Latanoprost/Timolol Viatris

Latanoprost and Timolol, the active ingredients in Latanoprost/Timolol Viatris, are a prostaglandin analog/beta‑blocker combination presented as eye drops for ocular use. They lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost/Timolol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol is used in the management of ocular conditions that require reduction of intra‑ocular pressure.

- Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent development of glaucoma. - Glaucoma (any type) where pressure reduction is needed: provides additive pressure‑lowering effect when monotherapy is insufficient.

The following adverse reactions have been reported with Latanoprost/Timolol eye drops.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision. - Conjunctival hyperemia (redness). - Increased eyelash growth. - Darkening of the iris. - Ocular discomfort or foreign body sensation.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Exacerbation of asthma or chronic obstructive pulmonary disease. - Bradycardia or hypotension. - Systemic beta‑blocker effects such as fatigue or depression. - Corneal ulceration or keratitis. - Persistent intra‑ocular pressure reduction leading to hypotony.

Before prescribing Latanoprost/Timolol, clinicians should consider the following precautions.

- Assess beta‑blocker contraindications: avoid in patients with asthma, COPD, severe bradycardia, or heart block. - Monitor intra‑ocular pressure: ensure adequate pressure reduction without causing hypotony. - Evaluate for sulfonamide allergy if preservative contains sulfonamide. - Do not instill other eye medications within 5 minutes of this product to prevent wash‑out. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost/Timolol may interact with other medicines; relevant interactions are grouped below.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): risk of additive bradycardia and hypotension. - Sympathomimetic eye drops (e.g., epinephrine): may diminish intra‑ocular pressure‑lowering effect. - Other ocular hypotensive agents used concurrently: risk of excessive pressure reduction (hypotony).

Moderate Interactions (Monitor Closely):\n- Calcium channel blockers: may influence ocular blood flow. - Anticholinergic eye drops: potential effect on pupil size and accommodation. - Topical anesthetics: increased risk of corneal toxicity when used together.